Filing Details

Accession Number:
0001562180-18-002370
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-05-08 16:51:27
Reporting Period:
2018-05-08
Accepted Time:
2018-05-08 16:51:27
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597553 Sage Therapeutics Inc. SAGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1235598 M James Frates C/O Sage Therapeutics, Inc.
215 First Street
Cambridge MA 02142
No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2018-05-08 7,000 $8.92 12,000 No 4 M Direct
Common Stock Disposition 2018-05-08 7,000 $154.00 5,000 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Disposition 2018-05-08 7,000 $0.00 7,000 $8.92
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,809 2024-05-21 No 4 M Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. Shares vest 25% on first anniversary of grant and quarterly thereafter beginning on May 26, 2014.